The use of triptans as an effective form of migraine treatment – review
Introduction Migraine, a prevalent neurological disorder, is characterized by recurrent episodes of moderate to severe headache, often accompanied by symptoms such as nausea, photophobia, and phonophobia. Triptans, which belong to the class of serotonin 5-HT1B/1D receptor agonists, are integral to...
Saved in:
Main Authors: | Agata Borkowska, Anna Kiełb, Anna Mich, Anna Kaźmierczak, Patrycja Sornek, Wiktoria Izdebska, Igor Pawlak, Radosław Ciesielski, Jakub Stanek, Klaudia Perkowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Nicolaus Copernicus University in Toruń
2025-01-01
|
Series: | Quality in Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/QS/article/view/56600 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NSAIDs and Triptans – a (not) New Treatment Option for Migraine
by: B. Kakta, et al.
Published: (2023-12-01) -
Effects of new generation triptans – frovatriptan and almotriptan – on hemodynamic parameters in intact male and female rats
by: Saracheva Kremena, et al.
Published: (2020-06-01) -
Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study)
by: Luigi Francesco Iannone, et al.
Published: (2025-01-01) -
Epidemiology of clinically significant migraine in Israel: a retrospective database study
by: A. Shifrin, et al.
Published: (2025-02-01) -
The impact of headache specialist density and the introduction of gepants and lasmitidan on prescriptions for acute migraine treatments: a regression and interrupted time series analysis
by: Leon S. Moskatel, et al.
Published: (2025-02-01)